Effect of the Dual 5Α-REDUCTASE Inhibitor Dutasteride on Markers of Tumor Regression in Prostate Cancer (original) (raw)
The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer—results from a 4-month pre-radical prostatectomy study
P.eter Pommerville
The Prostate, 2006
View PDFchevron_right
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
Scott Lucia
Lancet, 2012
View PDFchevron_right
Effect of Dutasteride on the Risk of Prostate Cancer
Claudio Teloken
New England Journal of Medicine, 2010
View PDFchevron_right
Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts
D. Tindall, Karla Ballman
The Prostate, 2009
View PDFchevron_right
CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
Donald Tindall
The Journal of Urology, 2004
View PDFchevron_right
Effects of the dual 5 α-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines
Niall Mulligan
Cancer, 2006
View PDFchevron_right
Effects of Dutasteride on Prostate Growth in the Large Probasin-Large T Antigen Mouse Model of Prostate Cancer
Glenn Cunningham
The Journal of Urology, 2007
View PDFchevron_right
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia in the Combination of Avodart and Tamsulosin (CombAT) trial
Ramiro Castro, Jack Barkin, Andrea Tubaro, Steven Kaplan
Journal of Men's Health, 2009
View PDFchevron_right
Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride
Donald Tindall
Journal of andrology
View PDFchevron_right
Altered Androgen Metabolism Induced by Dutasteride and Finasteride in Vitro: Implications in Prostate Cancer Prevention
Harris Ford
Journal of Urology, 2008
View PDFchevron_right
Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Glenn Cunningham
The Journal of Clinical Endocrinology & Metabolism, 2004
View PDFchevron_right
Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models
Bushra Ateeq
The Prostate, 2012
View PDFchevron_right
Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride
Laura Pascal
American journal of clinical and experimental urology, 2014
View PDFchevron_right
Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study
Girish Kulkarni
BMJ (Clinical research ed.), 2013
View PDFchevron_right
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical Trial
M. Winkler
The Journal of urology, 2016
View PDFchevron_right
Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride
Donald Tindall
Prostate, 2007
View PDFchevron_right
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
Claus Roehrborn
Urology, 2002
View PDFchevron_right
Impact of short‐term Dutasteride treatment on prostate‐specific membrane antigen expression in a mouse xenograft model
Rosa Sousa
Cancer Reports, 2021
View PDFchevron_right
The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE Study
Stephen Freedland
The Journal of Urology, 2011
View PDFchevron_right
A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer
Mack Roach
BJU International, 2011
View PDFchevron_right
Steroid Hormone Receptors as Potential Mediators of the Clinical Effects of Dutasteride: A Prospective, Randomized, Double-Blind Study
Leonardo O Reis
American Journal of Men's Health, 2015
View PDFchevron_right
Effect of Dutasteride on Prostate Biopsy Rates and the Diagnosis of Prostate Cancer in Men with Lower Urinary Tract Symptoms and Enlarged Prostates in the Combination of Avodart and Tamsulosin Trial
Ramiro Castro
European Urology, 2011
View PDFchevron_right
Effect of Short-term Dutasteride Therapy on Prostate Vascularity in Patients With Benign Prostatic Hyperplasia: A Pilot Study
sergey kravchick
Urology, 2009
View PDFchevron_right
Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia
Mario Reis
European Urology, 2004
View PDFchevron_right
Variability in the Androgen Response of Prostate Epithelium to 5 -Reductase Inhibition: Implications for Prostate Cancer Chemoprevention
Ilsa Coleman
Cancer Res, 2010
View PDFchevron_right